Biotech
TORONTO, ONTARIO: John Mitchell, Noted Pharmaceutical Sales and Marketing Professional, Accepts Position as Vice President of Sales-North America ...
BUFFALO, NY: BUFFALO, NY -- (Marketwire) -- 09/26/11 -- (NASDAQ: CBLI) today announced that it has entered into an agreement with Open Joint Stock Company RUSNANO, a $10 billion Russian Federation fund with a mi ...
TUSTIN, CA: HCV Trial Evaluating 12 Weeks of Therapy With Bavituximab With Ribavirin; Early Virologic Response (EVR) Data Expected by End of 2011 or Early 2012 ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 09/26/11 -- Warnex Inc. (TSX: WNX) announced today that its Bioanalytical Services division participated in the international External Quality Assessment Scheme (DEQ ...
MONTREAL, CANADA: - Increased offer will be made upon cease-trade of Afexa Rights Plans - 14% premium to the Valeant bid - Choice of $0.81 in cash or 0.0217 of a Paladin share per Afexa share - Offer remains for any an ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 09/23/11 -- Medivation, Inc. (NASDAQ: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the following two inves ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 09/23/11 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in develo ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwire) -- 09/22/11 -- PharmaGap Inc. (TSX VENTURE: GAP)(OTCBB: PHRGF) ("PharmaGap" or "the Company") announced today that it has completed the conditiona ...
GAITHERSBURG, MD: GAITHERSBURG, MD -- (Marketwire) -- 09/22/11 -- VIRxSYS Corporation, a Maryland-based biotechnology company, today announced that the United States Patent and Trademark Office has issued a third pate ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 09/22/11 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests and risk assessment tool ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 09/22/11 -- Paladin Labs Inc. ("Paladin" or the "Company") (TSX: PLB), a leading Canadian diversified specialty pharmaceutical company, today ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 09/22/11 -- Warnex Inc. (TSX: WNX) announced today that its subsidiary, Warnex PRO-DNA Services, located in Thunder Bay, Ontario, has signed a Contribution Agreement ...
LAVAL, QUEBEC: ProMetic further expands their Asian reach through leading Chinese biopharmaceutical companies ProMetic's proven technologies to provide significant economic and competitive advantages ...
BOISE, ID: BOISE, ID -- (Marketwire) -- 09/21/11 -- MWI Veterinary Supply, Inc. ("MWI" or "the Company") (NASDAQ: MWIV) announced today that it has entered into a definitive agreement to ac ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 09/21/11 -- Easton Pharmaceuticals, (OTC: EAPH) a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered ther ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 09/20/11 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment ...
BOSTON, MA: First-in-Man Study Commenced for Novel Biologic With Potential to Treat Autoimmune Disorders and Allergic Conditions ...
BUFFALO, NY: BUFFALO, NY -- (Marketwire) -- 09/19/11 -- (NASDAQ: CBLI) today announced that Incuron has been awarded a $5 million grant through the Russian Federation Government initiative "Skolkovo" ...
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN -- (Marketwire) -- 09/19/11 -- Sunshine Heart, Inc. (ASX: SHC), today announced it closed its two-tranche financing on September 16, 2011, raising a total of A ...
MELBOURNE, AUSTRALIA: Important Further Demonstration of Mechanism of Action; Journal of Neurochemistry Publication on Biochemical Effects of PBT2 Explains the Preclinical and Clinical Benefits of PBT2 in Alzheimer's ...
